There is a pressing need to enhance connectivity in the UK medicines R&D community, which is currently complex and fragmented.
The full strength of UK drug discovery is not working together effectively, meaning innovators are not benefiting from deep sector knowledge and available resources. This impacts chances of success and reduces the ability to address unmet patient needs.
We are bringing together innovators from across the sector to create national-scale R&D programmes and unlock innovation.
